Qingzhong Hua & Lu Ren. (2024). The SIRT1/Nrf2 signaling pathway mediates the anti-pulmonary fibrosis effect of liquiritigenin. BMC.
Chicago Style (17th ed.) CitationQingzhong Hua and Lu Ren. The SIRT1/Nrf2 Signaling Pathway Mediates the Anti-pulmonary Fibrosis Effect of Liquiritigenin. BMC, 2024.
MLA (9th ed.) CitationQingzhong Hua and Lu Ren. The SIRT1/Nrf2 Signaling Pathway Mediates the Anti-pulmonary Fibrosis Effect of Liquiritigenin. BMC, 2024.
Warning: These citations may not always be 100% accurate.